A carregar...
Tocilizumab for refractory organising pneumonia associated with Sjögren's disease
Lung involvement in primary Sjögren syndrome occurs in approximately 10–20% of patients. Tocilizumab, an anti-interleukin-6 receptor antibody, has demonstrated efficacy and safety in small series of systemic sclerosis, and systemic lupus erythematosus, but its effect on interstitial lung manifestati...
Na minha lista:
| Publicado no: | BMJ Case Rep |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4434320/ https://ncbi.nlm.nih.gov/pubmed/25976199 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2014-209076 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|